AbbVie Inc.
HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME

Abstract:

Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions.